Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04598750 · ClinicalTrials.gov registry record
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
A clinical trial of Bleeding and Neonatal Thrombocytopenia, sponsored by Karolinska Institutet.
- Recruiting
- Registry status
- 250
- Enrollment target
- 8
- Study locations
NCT04598750 is a study of Bleeding and Neonatal Thrombocytopenia that is actively recruiting participants, run by Karolinska Institutet. The registered enrollment target is 250 participants, below the 1,474-participant average among 23 other Bleeding trials with a reported enrollment target (83% lower). The trial reports 8 study locations across 3 states.
The verdict
NCT04598750, a study of Bleeding and Neonatal Thrombocytopenia, is actively recruiting participants, sponsored by Karolinska Institutet.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a prospective observational study designed to evaluate Immature Platelet Fraction or Immature Platelet Count and Platelet Function Analyzer-100/200 Closure Time-ADP (in vitro bleeding time) as markers of bleeding risk in thrombocytopenic preterm neonates admitted to the Neonatal Intensive Care Unit.
Conditions Studied
Study Locations (8)
Other
- Amsterdam University Medical Centre - Amsterdam
- Leiden University Medical Center - Leiden
- Karolinska University Hospital Huddinge campus - Huddinge
- Karolinska University Hospital Solna campus, Astrid Lindgren Children's Hospital - Stockholm
Massachusetts
- Boston Children's Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Utah
- Intermountain Medical Center - Murray
- Utah Valley Hospital - Provo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-06-15 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04598750
The ClinicalTrials.gov registry entry for NCT04598750 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,474-participant average among 23 other Bleeding trials with a reported enrollment target (83% lower). The listed sponsor is Karolinska Institutet, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bleeding appearing as the primary indexed condition, and to 0 interventions.
NCT04598750 reports 8 study locations spanning 3 distinct geographic areas - top geographies include Other, Massachusetts, Utah.
Frequently Asked Questions
What is clinical trial NCT04598750 about?
NCT04598750 is a clinical study titled "The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia". This is a prospective observational study designed to evaluate Immature Platelet Fraction or Immature Platelet Count and Platelet Function Analyzer-100/200 Closure Time-ADP (in vitro bleeding time) as markers of bleeding risk in thrombocytopenic preterm neonates admitted to the Neonatal Intensive Ca...
What is the current status of trial NCT04598750?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2021-06-15. Estimated completion is 2025-12-31.
What conditions does trial NCT04598750 study?
This clinical trial studies the following conditions: Bleeding, Neonatal Thrombocytopenia.
Who is sponsoring clinical trial NCT04598750?
This trial is sponsored by Karolinska Institutet, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04598750 being conducted?
This trial has 8 study locations across Massachusetts, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bleeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
RECRUITING · Phase 2
-
Quantra Point-of-Care Hemostasis Monitoring
RECRUITING · NA
-
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
RECRUITING · Phase 4
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
RECRUITING · Phase 3
-
Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders
RECRUITING
-
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.